These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 28600641

  • 21. Loss of genetic material within 1p and 19q chromosomal arms in low grade gliomas of central nervous system.
    Ręcławowicz D, Stempniewicz M, Biernat W, Limon J, Słoniewski P.
    Folia Neuropathol; 2013; 51(1):26-32. PubMed ID: 23553134
    [Abstract] [Full Text] [Related]

  • 22. Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas.
    Nishikawa T, Ohka F, Aoki K, Suzuki H, Motomura K, Yamaguchi J, Maeda S, Kibe Y, Shimizu H, Natsume A, Innan H, Saito R.
    Brain Tumor Pathol; 2023 Apr; 40(2):85-92. PubMed ID: 36991274
    [Abstract] [Full Text] [Related]

  • 23. Predicting 1p/19q co-deletion status from magnetic resonance imaging using deep learning in adult-type diffuse lower-grade gliomas: a discovery and validation study.
    Yan J, Zhang S, Sun Q, Wang W, Duan W, Wang L, Ding T, Pei D, Sun C, Wang W, Liu Z, Hong X, Wang X, Guo Y, Li W, Cheng J, Liu X, Li ZC, Zhang Z.
    Lab Invest; 2022 Feb; 102(2):154-159. PubMed ID: 34782727
    [Abstract] [Full Text] [Related]

  • 24. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
    Stockhammer F, Thomale UW, Plotkin M, Hartmann C, Von Deimling A.
    J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
    [Abstract] [Full Text] [Related]

  • 25. Long-term impact of temozolomide on 1p/19q-codeleted low-grade glioma growth kinetics.
    Izquierdo C, Alentorn A, Idbaih A, Simó M, Kaloshi G, Ricard D, Barritault M, Meyronet D, Bruna J, Honnorat J, Delattre JY, Ducray F.
    J Neurooncol; 2018 Feb; 136(3):533-539. PubMed ID: 29143276
    [Abstract] [Full Text] [Related]

  • 26. Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.
    Li G, Huang R, Fan W, Wang D, Wu F, Zeng F, Yu M, Zhai Y, Chang Y, Pan C, Jiang T, Yan W, Wang H, Zhang W.
    Front Immunol; 2021 Feb; 12():800928. PubMed ID: 34956239
    [Abstract] [Full Text] [Related]

  • 27. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 28. MRI features predict survival and molecular markers in diffuse lower-grade gliomas.
    Zhou H, Vallières M, Bai HX, Su C, Tang H, Oldridge D, Zhang Z, Xiao B, Liao W, Tao Y, Zhou J, Zhang P, Yang L.
    Neuro Oncol; 2017 Jun 01; 19(6):862-870. PubMed ID: 28339588
    [Abstract] [Full Text] [Related]

  • 29. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.
    Kanazawa T, Minami Y, Takahashi H, Fujiwara H, Toda M, Jinzaki M, Yoshida K, Sasaki H.
    Neurosurg Rev; 2020 Aug 01; 43(4):1211-1219. PubMed ID: 31402410
    [Abstract] [Full Text] [Related]

  • 30. Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
    Tang L, Deng L, Bai HX, Sun J, Neale N, Wu J, Wang Y, Chang K, Huang RY, Zhang PJ, Li X, Xiao B, Cao Y, Tao Y, Yang L.
    J Neurooncol; 2018 Sep 01; 139(3):563-571. PubMed ID: 29923053
    [Abstract] [Full Text] [Related]

  • 31. Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors.
    Chamberlain MC, Born D.
    J Neurooncol; 2015 Nov 01; 125(2):249-51. PubMed ID: 26341371
    [Abstract] [Full Text] [Related]

  • 32. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study.
    Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM.
    Sci Rep; 2020 Jul 17; 10(1):11922. PubMed ID: 32681084
    [Abstract] [Full Text] [Related]

  • 33. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
    Peng X, Yishuang C, Kaizhou Z, Xiao L, Ma C.
    J Comput Assist Tomogr; 2019 Jul 17; 43(2):269-276. PubMed ID: 30371623
    [Abstract] [Full Text] [Related]

  • 34. Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas.
    Alentorn A, van Thuijl HF, Marie Y, Alshehhi H, Carpentier C, Boisselier B, Laigle-Donadey F, Mokhtari K, Scheinin I, Wesseling P, Ylstra B, Capelle L, Hoang-Xuan K, Sanson M, Delattre JY, Reijneveld JC, Idbaih A.
    Neuro Oncol; 2014 Mar 17; 16(3):400-8. PubMed ID: 24335697
    [Abstract] [Full Text] [Related]

  • 35. Automated glioma grading on conventional MRI images using deep convolutional neural networks.
    Zhuge Y, Ning H, Mathen P, Cheng JY, Krauze AV, Camphausen K, Miller RW.
    Med Phys; 2020 Jul 17; 47(7):3044-3053. PubMed ID: 32277478
    [Abstract] [Full Text] [Related]

  • 36. MR textural analysis on T2 FLAIR images for the prediction of true oligodendroglioma by the 2016 WHO genetic classification.
    Rui W, Ren Y, Wang Y, Gao X, Xu X, Yao Z.
    J Magn Reson Imaging; 2018 Jul 17; 48(1):74-83. PubMed ID: 29140606
    [Abstract] [Full Text] [Related]

  • 37. Reduced H3K27me3 levels in diffuse gliomas: association with 1p/19q codeletion and difference from H3K27me3 loss in malignant peripheral nerve sheath tumors.
    Kitahama K, Iijima S, Sumiishi A, Hayashi A, Nagahama K, Saito K, Sasaki N, Kobayashi K, Shimizu S, Nagane M, Shibahara J.
    Brain Tumor Pathol; 2021 Jan 17; 38(1):23-29. PubMed ID: 32989606
    [Abstract] [Full Text] [Related]

  • 38. Development and external validation of a non-invasive molecular status predictor of chromosome 1p/19q co-deletion based on MRI radiomics analysis of Low Grade Glioma patients.
    Casale R, Lavrova E, Sanduleanu S, Woodruff HC, Lambin P.
    Eur J Radiol; 2021 Jun 17; 139():109678. PubMed ID: 33848780
    [Abstract] [Full Text] [Related]

  • 39. Biological tumour volumes of gliomas in early and standard 20-40 min 18F-FET PET images differ according to IDH mutation status.
    Unterrainer M, Winkelmann I, Suchorska B, Giese A, Wenter V, Kreth FW, Herms J, Bartenstein P, Tonn JC, Albert NL.
    Eur J Nucl Med Mol Imaging; 2018 Jul 17; 45(7):1242-1249. PubMed ID: 29487977
    [Abstract] [Full Text] [Related]

  • 40. Predicting chromosome 1p/19q codeletion by RNA expression profile: a comparison of current prediction models.
    Wang ZL, Zhao Z, Wang Z, Zhang CB, Jiang T.
    Aging (Albany NY); 2019 Feb 02; 11(3):974-985. PubMed ID: 30710490
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.